{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 470620672
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = zu/o
| target = ''[[E. coli]]'' [[Shiga-like toxin]] II B subunit
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 502496-16-4
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| C=6414 | H=9934 | N=1718 | O=2010 | S=40
| molecular_weight = 144.6 kg/mol
}}

'''Urtoxazumab''' is a [[humanized monoclonal antibody]] against [[diarrhoea]] caused by ''[[Escherichia coli]]'', serotype [[Escherichia coli O121|O121]]. The drug is designed to bind to a [[toxin]] of this bacterium, so that it can be more easily broken down and eliminated from the body.<ref>[http://whqlibdoc.who.int/druginfo/18_1_2004_INN.pdf International Nonproprietary Names for Pharmaceutical Substances (INN)], ''World Health Organization''.</ref><ref>{{cite journal|year=2009|last1=López|first1=EL|last2=Contrini|first2=MM|last3=Glatstein|first3=E|last4=González Ayala|first4=S|last5=Santoro|first5=R|last6=Allende|first6=D|last7=Ezcurra|first7=G|last8=Teplitz|first8=E|last9=Koyama|first9=T|last10=Matsumoto|first10=Y.|last11=Sato|first11=H.|last12=Sakai|first12=K.|last13=Hoshide|first13=S.|last14=Komoriya|first14=K.|last15=Morita|first15=T.|last16=Harning|first16=R.|last17=Brookman|first17=S.|title=Safety and Pharmacokinetics of Urtoxazumab, a Humanized Monoclonal Antibody Against Shiga-Like Toxin 2 in Healthy Adults and Pediatric STEC- Infected Patients|doi=10.1128/AAC.00343-09|journal=Antimicrobial Agents and Chemotherapy|pmid=19822704|volume=54|pages=239–243|issue=1|pmc=2798559|display-authors=8}}</ref>

== References ==
<references/>

{{Monoclonals for infectious disease and toxins}}

[[Category:Monoclonal antibodies]]
[[Category:Experimental drugs]]


{{antiinfective-drug-stub}}
{{monoclonal-antibody-stub}}